Landmark Peer-Reviewed Study on Pfizer and Moderna Covid Vaccines Confirms 'Excess Risk'

"In the Pfizer trial, the excess risk of serious AESIs (10.1 per 10,000) was higher than the risk reduction for COVID-19 hospitalization relative to the placebo group"...


Kyle Becker

A landmark peer-reviewed study appears to be the first of its kind to provide hard data on the "excess risk" of adverse side effects of Pfizer-BioNTech and Moderna mRNA vaccines in an independent randomized control trial. The results of the accepted scientific study confirm that the concerns that many patients had about the mRNA vaccines were well-founded.


"In the Moderna trial, the excess risk of serious AESIs (15.1 per 10,000 participants) was higher than the risk reduction for COVID-19 hospitalization relative to the placebo group (6.4 per 10,000 participants)," the study found.

"In the Pfizer trial, the excess risk of serious AESIs (10.1 per 10,000) was higher than the risk reduction for COVID-19 hospitalization relative to the placebo group (2.3 per 10,000 participants)," the study added.


CONTINUE READING

https://thekylebecker.substack.com/p/breaking-landmark-first-peer-reviewed